CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 92 filers reported holding CYTOKINETICS INC in Q4 2013. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,487,304 | -25.7% | 84,430 | -17.8% | 0.00% | 0.0% |
| Q2 2023 | $3,348,895 | +29.5% | 102,664 | +39.7% | 0.00% | 0.0% |
| Q1 2023 | $2,585,454 | +126.8% | 73,471 | +195.3% | 0.00% | – |
| Q4 2022 | $1,139,956 | -1.0% | 24,879 | +4.7% | 0.00% | – |
| Q3 2022 | $1,152,000 | +19.6% | 23,762 | -3.0% | 0.00% | – |
| Q2 2022 | $963,000 | -76.0% | 24,497 | -77.5% | 0.00% | -100.0% |
| Q1 2022 | $4,006,000 | -25.8% | 108,821 | -8.1% | 0.00% | 0.0% |
| Q4 2021 | $5,396,000 | +82.5% | 118,376 | +43.1% | 0.00% | 0.0% |
| Q3 2021 | $2,956,000 | +246.9% | 82,733 | +92.3% | 0.00% | – |
| Q2 2021 | $852,000 | -55.4% | 43,034 | -47.6% | 0.00% | – |
| Q1 2021 | $1,909,000 | -41.8% | 82,058 | -48.0% | 0.00% | -100.0% |
| Q4 2020 | $3,281,000 | +22.7% | 157,902 | +27.9% | 0.00% | 0.0% |
| Q3 2020 | $2,673,000 | -14.1% | 123,460 | -6.5% | 0.00% | 0.0% |
| Q2 2020 | $3,113,000 | +115.7% | 132,084 | +7.9% | 0.00% | – |
| Q1 2020 | $1,443,000 | +10.4% | 122,431 | -0.7% | 0.00% | – |
| Q4 2019 | $1,307,000 | +10.0% | 123,264 | +18.1% | 0.00% | – |
| Q3 2019 | $1,188,000 | +17.9% | 104,385 | +16.6% | 0.00% | – |
| Q2 2019 | $1,008,000 | +334.5% | 89,557 | +211.7% | 0.00% | – |
| Q1 2019 | $232,000 | +28.9% | 28,728 | +0.8% | 0.00% | – |
| Q4 2018 | $180,000 | -35.0% | 28,505 | +1.3% | 0.00% | – |
| Q3 2018 | $277,000 | +27.6% | 28,134 | +7.4% | 0.00% | – |
| Q2 2018 | $217,000 | -57.6% | 26,203 | -63.2% | 0.00% | – |
| Q1 2018 | $512,000 | -13.1% | 71,156 | -1.5% | 0.00% | – |
| Q4 2017 | $589,000 | -19.6% | 72,247 | +43.0% | 0.00% | – |
| Q3 2017 | $733,000 | +78.3% | 50,523 | +48.7% | 0.00% | – |
| Q2 2017 | $411,000 | -18.6% | 33,968 | -13.6% | 0.00% | – |
| Q1 2017 | $505,000 | +55.4% | 39,308 | +46.9% | 0.00% | – |
| Q4 2016 | $325,000 | +125.7% | 26,766 | +71.3% | 0.00% | – |
| Q3 2016 | $144,000 | +2.1% | 15,627 | +5.1% | 0.00% | – |
| Q2 2016 | $141,000 | -66.0% | 14,867 | -74.7% | 0.00% | – |
| Q1 2016 | $415,000 | -30.9% | 58,850 | +2.5% | 0.00% | – |
| Q4 2015 | $601,000 | +33.9% | 57,424 | -14.4% | 0.00% | – |
| Q3 2015 | $449,000 | +3.5% | 67,074 | +3.9% | 0.00% | – |
| Q2 2015 | $434,000 | -38.0% | 64,577 | -37.5% | 0.00% | – |
| Q1 2015 | $700,000 | +1272.5% | 103,348 | +1502.3% | 0.00% | – |
| Q4 2014 | $51,000 | +218.8% | 6,450 | +43.6% | 0.00% | – |
| Q3 2014 | $16,000 | -90.6% | 4,492 | -87.4% | 0.00% | – |
| Q2 2014 | $170,000 | -67.0% | 35,602 | -34.2% | 0.00% | – |
| Q1 2014 | $515,000 | +8483.3% | 54,140 | +5314.0% | 0.00% | – |
| Q4 2013 | $6,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2013 | $8,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |